Franklin Genomic Advancements ETF

Yield per half year: -17.86%
Industry: Health & Biotech Equities

Compare ETFs

Clear list

Price chart

Franklin Genomic Advancements ETF

Simple chart Extended chart
36.000036.000032.000032.000028.000028.000024.000024.000020.000020.000020242024Feb '24Feb '24Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25
RSI10010050500020242024Feb '24Feb '24Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25

SPDR S&P 500 ETF Trust

Simple chart Extended chart
650.000650.000600.000600.000550.000550.000500.000500.000450.000450.00020242024Feb '24Feb '24Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25
RSI10010050500020242024Feb '24Feb '24Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25

iShares Core S&P 500 ETF

Simple chart Extended chart
650.00650.00600.00600.00550.00550.00500.00500.00450.00450.0020242024Feb '24Feb '24Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25
RSI10010050500020242024Feb '24Feb '24Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25

Top 15 ETF Issuers

Franklin Genomic Advancements ETF SPDR S&P 500 ETF Trust iShares Core S&P 500 ETF
Company Share, %
Company Share, %
Company Share, %
More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe